Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of Resminostat Monotherapy and Resminostat + S-1 in Biliary Tract or Pancreatic Cancer
jRCT2080222812Phase 1
- Sponsor
- Yakult Honsha
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of Resminostat in biliary cancer, intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (eCCA) and 3 more (2 arms), sponsored by Yakult Honsha.
02
Drugs
Resminostat
03
Conditions
biliary cancerintrahepatic cholangiocarcinoma (ICC)extrahepatic cholangiocarcinoma (eCCA)gallbladder cancerAmpullary cancer (AC)
Beyond the preview
Go deeper on jRCT2080222812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222812.